NEW YORK, June 6 (Reuters) - Pfizer (PFE.N), opens new tab presented data on Saturday that showed a monthly dose of an experimental obesity drug it acquired through ‌its purchase of Metsera last year ...

In a 32-week extension of its phase 2b VESPER-1 study, patients with obesity or overweight who escalated from placebo to a 2.4 mg weekly dose of berobenatide achieved a non-placebo-adjusted weight ...

PFE trades at just 8x forward earnings while paying a near-7% dividend yield, and the five-year base case model targets $49. Pfizer's Berobenatide GLP-1 posted 16% weight loss at 32 weeks with no ...

Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The ...

When you boil it all down, the board of directors decides on a company's dividend policy. It is entirely up to this group. Obviously, they don't work in a vacuum. The board consults with a company's ...

An alternative to Paxlovid, the only antiviral pills approved by the US Food and Drug Administration to treat COVID-19, is on the horizon. Pfizer—the maker of Paxlovid—has begun Phase 3 clinical ...

All the codes above have been tested as working at the time of submission. However, codes with unknown expiry dates may stop working at any time. Spotted a new code we haven't included or tried one ...

Pfizer Inc. is pulling back the curtain on its obesity ambitions, releasing new data on an experimental weight-loss shot and outlining a strategy to claw its way into a leadership position in the ...

Looking to snag some free resources in Fisch? We've put together a list of all currently active and working Fisch codes, so you can get your hands on a host of rewards and goodies in the Roblox ...

2nd July 2026: We added new Solo Leveling Arise codes. Solo Leveling: Arise is a mobile RPG based on the Korean web novel Solo Leveling, which was recently adapted into a hit anime. In Solo Leveling: ...